A recent research from Zhang et al. reported that RFWD3 was more elevated in tumor samples in comparison with matched normal lung tissues and was closely linked to the clinical outcomes of patients with non-small cell lung cancer, which implied that RFWD3 exerted a promoting effect on lung carcinogenesis (Zhang et al., 2020). This evidence concerns the gene RFWD3 and neoplasm.